Annual Cash & Cash Equivalents
$11.79 M
+$4.48 M+61.32%
December 31, 2023
Summary
- As of February 12, 2025, GANX annual cash & cash equivalents is $11.79 million, with the most recent change of +$4.48 million (+61.32%) on December 31, 2023.
- During the last 3 years, GANX annual cash & cash equivalents has risen by +$4.30 million (+57.41%).
- GANX annual cash & cash equivalents is now -68.02% below its all-time high of $36.88 million, reached on December 31, 2021.
Performance
GANX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$12.05 M
-$4.89 M-28.85%
September 30, 2024
Summary
- As of February 12, 2025, GANX quarterly cash and cash equivalents is $12.05 million, with the most recent change of -$4.89 million (-28.85%) on September 30, 2024.
- Over the past year, GANX quarterly cash and cash equivalents has increased by +$254.60 thousand (+2.16%).
- GANX quarterly cash and cash equivalents is now -74.14% below its all-time high of $46.59 million, reached on March 31, 2021.
Performance
GANX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GANX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +61.3% | +2.2% |
| 3 y3 years | +57.4% | -67.3% |
| 5 y5 years | - | -67.3% |
GANX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -68.0% | +61.3% | -67.3% | +182.0% |
| 5 y | 5-year | -68.0% | +3788.9% | -74.1% | +182.0% |
| alltime | all time | -68.0% | +3788.9% | -74.1% | +182.0% |
Gain Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $12.05 M(-28.9%) |
| Jun 2024 | - | $16.94 M(+59.2%) |
| Mar 2024 | - | $10.64 M(-9.8%) |
| Dec 2023 | $11.79 M(+61.3%) | $11.79 M(+176.1%) |
| Sep 2023 | - | $4.27 M(-32.4%) |
| Jun 2023 | - | $6.32 M(+5.5%) |
| Mar 2023 | - | $5.99 M(-18.1%) |
| Dec 2022 | $7.31 M | $7.31 M(-32.8%) |
| Sep 2022 | - | $10.88 M(-23.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $14.31 M(-58.3%) |
| Mar 2022 | - | $34.34 M(-6.9%) |
| Dec 2021 | $36.88 M(+392.2%) | - |
| Dec 2021 | - | $36.88 M(-10.0%) |
| Sep 2021 | - | $40.98 M(-5.1%) |
| Jun 2021 | - | $43.16 M(-7.4%) |
| Mar 2021 | - | $46.59 M(+521.8%) |
| Dec 2020 | $7.49 M(+2370.5%) | - |
| Dec 2020 | - | $7.49 M |
| Dec 2019 | $303.30 K | - |
FAQ
- What is Gain Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Gain Therapeutics?
- What is Gain Therapeutics annual cash & cash equivalents year-on-year change?
- What is Gain Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Gain Therapeutics?
- What is Gain Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Gain Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of GANX is $11.79 M
What is the all time high annual cash & cash equivalents for Gain Therapeutics?
Gain Therapeutics all-time high annual cash & cash equivalents is $36.88 M
What is Gain Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, GANX annual cash & cash equivalents has changed by +$4.48 M (+61.32%)
What is Gain Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of GANX is $12.05 M
What is the all time high quarterly cash and cash equivalents for Gain Therapeutics?
Gain Therapeutics all-time high quarterly cash and cash equivalents is $46.59 M
What is Gain Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, GANX quarterly cash and cash equivalents has changed by +$254.60 K (+2.16%)